title: [Clinical significance of the terminal complement complex in children with type I membranoproliferative glomerulonephritis].
authors.affiliation: Division of Pediatrics, Ohtawara Red Cross Hospital, Tochigi, Japan.
authors.forename: Yasuaki
authors.initials: Y
authors.lastname: Kobayashi
authors.forename: Osamu
authors.initials: O
authors.lastname: Hasegawa
authors.forename: Masataka
authors.initials: M
authors.lastname: Honda
mesh_terms: D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D015415:Biomarkers / Q000032:analysis / Q000097:blood; D002648:Child; D015938:Complement Membrane Attack Complex / Q000032:analysis*; D004359:Drug Therapy, Combination; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D015432:Glomerulonephritis, Membranoproliferative / Q000175:diagnosis* / Q000188:drug therapy / Q000378:metabolism; D006801:Humans; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage; D011239:Prednisolone / Q000008:administration & dosage; D011379:Prognosis
chemical_list: D000893:Anti-Inflammatory Agents; D015415:Biomarkers; D015938:Complement Membrane Attack Complex; D011239:Prednisolone; D008775:Methylprednisolone